Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Julphar
Accenture
Farmers Insurance
McKinsey
Deloitte
Harvard Business School
Teva
Cantor Fitzgerald

Drugs facing the most patent expirations this year

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities.

Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril from loss of patent protection.

This chart shows which pharmaceutical companies face the most patent expirations this year.

The drug companies facing the most patent expirations this year are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the plans and pricing